Lack of reimbursement an issue for digital health products, says survey
CMA provisionally finds Concordia overpriced thyroid drug.
Aspen pulled drugs from some countries that rejected price hikes, says EU.
US authorities suspicious over marketing, rebates and payment support programmes.
FDA approves Samsung Bioepis biosimilar.
Costly accounting error for Sanofi.